Objectives: To compare the diagnostic performance of computed tomography, magnetic resonance imaging and contrast enhanced ultrasonography for the assessment of complex renal cysts. Methods: We carried out a prospective single-center study from January 2012 to December 2013. We included patients with Bosniak category 2F or 3 renal cysts found on computed tomography and reviewed by two expert radiologists. Magnetic resonance imaging and contrast-enhanced ultrasonography were then carried out. Patients with a Bosniak ≥3 cyst on magnetic resonance imaging, as well as those upgraded as appearing malignant on contrast-enhanced ultrasonography, were surgically managed. Imaging results were compared with histological data. For patients without surgery, imaging examinations were compared with follow-up data. For each imaging examination, diagnostic performance and Cohen's kappa coefficient were assessed. Results: A total of 47 patients were included. The median follow up was 36 months (range 17-48 months). At initial computed tomography, cysts were classified as Bosniak 2F and Bosniak ≥3 in 34 and 13 patients, respectively. Magnetic resonance imaging found 13 Bosniak ≥3 cysts, and contrast-enhanced ultrasonography upgraded six more patients with cysts that appeared malignant. A total of 19 patients had surgery. Histological analysis reported 14 malignant tumors. No tumor progression was found in followed-up patients. Computed tomography showed poor sensitivity (36%) and specificity (76%; j = 0.11). Magnetic resonance imaging showed 71% sensitivity and 91% specificity (j = 0.64). Contrast-enhanced ultrasonography showed high sensitivity (100%) and specificity (97%), and a negative predictive value at 100% (j = 0.95). Conclusions: The present results suggested that contrast-enhanced ultrasonography could be useful in improving the assessment of complex renal cysts. Indeed, computed tomography accuracy might be limited in this indication requiring further investigations to determine the best treatment strategy.
Introduction
Renal cysts are frequently encountered in clinical practice, with an incidence rate of approximately 50% in patients aged >50 years. 1 At diagnosis, the main challenge is to discriminate benign cysts from cystic renal cell carcinomas requiring specific oncological care. These cystic cancers are reported in up to 10% of renal cancers. 2 Although radiological diagnosis of simple cysts and highly suspicious lesions is quite simple, characterizing complex cysts can be difficult. 2 Indeed, these atypical cysts consist of a set of benign or malignant lesions, and their characterization is sometimes difficult, but nonetheless essential to determine the best treatment strategy.
To date, the Bosniak classification is used most commonly to guide the management of renal cysts. It allows the classification of cysts according to morphological criteria, representative of their oncological potential. [3] [4] [5] However, in this classification, two categories remain undetermined: cysts 2F and 3 corresponding to malignant lesions, respectively, in 10% and 50% of cases. 6 For these cysts, the guidelines recommend using all imaging techniques available (MRI, CEUS and CT scan) as soon as necessary to narrow down the diagnosis. 6 In addition, biopsy of these cystic lesions is not recommended, thus limiting histological evidence for the best treatment strategy. 6, 7 As a result, the therapeutic decision is based mainly on radiological findings.
In this context, CEUS seems to be the optimal examination for characterization of these lesions. 8 Indeed, it provides a better time resolution than CT or MRI, because it allows a real-time view of enhancement. 8, 9 Thus, it improves the detection of blood vessels in renal masses. It also has a higher spatial resolution. 8, 9 As such, the advantages of CEUS make it a useful tool for improving the radiological diagnosis of atypical cysts, as several recent studies have suggested. [8] [9] [10] [11] [12] The aim of the present study was to compare the diagnostic performances of CEUS, CT scan and MRI in the treatment of atypical cystic renal tumors classified as Bosniak 2F or 3.
Methods Patients
We carried out a prospective single-center observational study from January 2012 to December 2013. During this period, 59 patients referred consecutively to our tertiary care center for an asymptomatic renal cyst Bosniak 2F or 3 on contrastenhanced CT were considered for inclusion. A total of 47 patients were definitely included after a centralized CT review by two expert radiologists had confirmed the cysts were Bosniak 2F or 3. Patients with contraindication to contrast-enhanced MRI were excluded, as well as patients with a symptomatic cyst and those without a CT scan available or of low quality, especially slice thickness >2.5 mm (see below). A flow chart of the study is represented in Figure 1 . All included patients gave their informed consent for renal MRI and CEUS for diagnostic purposes, and the principles of Helsinki were respected.
Radiological study
At Rouen University Hospital, Rouen, France, CTs were carried out with a 64-slice scanner (GE discovery HD 750; GE Healthcare, Chicago, IL, USA). Studies were carried out using 120 KVp and 280 mAs. Contrast media (1.5 mL/kg of non-ionic Omnipaque 350 mg/mL Ihhexol; GE Healthcare) was intravenously injected at the rate of 2-3 mL s through a power injector. Images were obtained at the unenhanced, nephrographic and early excretory phase. The following parameters were used: section 1.25/1.25 mm, pitch 1375, rotation time 0.7 s, detector width 0.675 9 64 = 40 mm, scan field of view 50 cm and matrix 512. 2 Outside CTs were also considered if they were carried out according to a similar protocol with slice thickness up to 2.5 mm. Renal MRI and CEUS were then carried out for each included patient within 1 month after enrolment. These radiological examinations were carried out blinded to previous imaging data.
CEUS
All CEUS were carried out by a third different radiologist, experienced in renal CEUS (>100 cases), according to a standardized protocol using ultrasonography machine ACUSON S2000-Siemens-10 (Siemens Healthcare, Erlangen, Germany). A convex probe was used with frequency ranging from 3 to 4.5 MHz. Each lesion was scanned first using unenhanced gray-scale ultrasonography in the harmonic mode. Then, each cyst was scanned after injection of an intravenous bolus of (1.2 mL) microbubbles (Sonovue; Bracco Imaging, Milan, Italy) followed by 10 mL normal saline flash. Technical parameters were: Cadence Contrast Pulse Sequencing (Acuson -Siemens Healthcare) as the contrast-specific mode with sensitivity similar to the microbubble harmonic signal, low transmission power insonation (mechanical index 0.06-0.1), dynamic range of 80 dB, temporal resolution between frames of 71-100 ms (10-14 frames/s) and one focus below the renal cyst. obtained before and after the intravenous administration of contrast media (Gadovist 1 mmol/mL; Bayer, Leverkusen, Germany) at the corticomedullary, nephrographic and delayed phases. For CT and MRI, the cystic lesions were classified according to the Bosniak classification using the described criteria for CT and MRI classification (3-5.13). A 1-mm threshold was used to determine the boundary between perceptible and measurable enhancement, and classify the cyst as 2F (perceptible, ≤1 mm) or 3 (measurable, >1 mm). CEUS classified the cysts as appearing benign or malignant. The malignancy criteria for CEUS were contrast enhancement of the septa and/or the walls, the same 1-mm threshold was used between perceptible and measurable. Perceptible enhancement was considered as benign.
Treatment strategy
Patients with a cyst described as Bosniak ≥3 on MRI and those with a cyst upgraded as appearing malignant on CEUS underwent surgical treatment (Fig. 1 ). For patients with both MRI and CEUS pointing to a benign lesion (≤Bosniak 2F), a follow up by renal imaging (CT or MRI) was scheduled every 6 months for 5 years, according to the guidelines. 3, 6 In cases of radiological progression during follow up, patients were offered surgical treatment.
Statistical analysis
Demographic, clinical and imaging data (including age at inclusion, sex, Bosniak classification, tumor location, surgical treatment and imaging follow-up data) were collected in a dedicated database at inclusion and during follow up. In addition, histological data were collected for patients who had surgery.
The initial radiological diagnosis of each examination (CT, MRI and CEUS) was compared with the final diagnosis in order to determine the sensitivity, specificity, PPV, NPV, accuracy and the rate of undetected cancers for each imaging technique. In this aim, the final diagnosis was defined according to Bertolotto et al. and Chen et al. 8, 9 For patients who had surgery, tumors were classified as either benign or malignant based on histological diagnosis. For patients followed up, classification was based on tumor progression on imaging examination, with a median follow up of 36 months (range 17-48 months). Lesions, which had not evolved at last follow-up imaging examination, were considered as benign.
The Cohen kappa coefficient was also calculated to assess the agreement of imaging techniques and final diagnosis.
Statistical analyses were made with the 12.0.3.0 version of MedCalc software (MedCalc Software bvba, Ostend, Belgium).
Results
A total of 47 patients were included in the present study -30 men (64%) and 17 women (36%). The median age was 64.7 years (range 37-76 years) with a median follow up of 36 months (range 17-48 months).
Patient and tumor characteristics are detailed in Table 1 . On CT, cysts were classified as Bosniak 2F and Bosniak 3 in 34 and 13 patients, respectively ( Table 2 ). On MRI, cysts were classified as Bosniak 2F and Bosniak ≥3 in 34 patients and 13 patients, respectively, with five patients upgraded to Bosniak ≥3 compared with CT scan (Table 2 ). On CEUS, 15 cysts (31.9%) were classified as malignant and 32 (68.1%) as benign, including nine patients who were upgraded to malignant compared with the CT results ( Table 2) .
A total of 19 patients (40%) had surgery according to the aforementioned criteria. Histological analysis found 14 malignant tumors and five benign tumors. Histological data are given in Table 1 . Among the 28 patients followed up, none presented any upgrade of their cyst during a median follow up of 36 months.
The diagnostic values of the different imaging examinations are detailed in Table 2 and Figure 2 . We found that CT had low sensitivity (36%) and specificity (76%), with a low kappa coefficient (0.11). MRI showed higher sensitivity (71%) and specificity (91%), and a kappa coefficient of 0.64 (range 0.39-0.88). CEUS showed superior results, with a sensitivity of 100% and a specificity of 97%, a positive predictive value of 93%, and a negative predictive value of 100%. Furthermore, it was the only examination with a 0% rate of undetected cancer. Finally, the kappa coefficient of CEUS was also high: 0.95 (range 0.85-1). Figure 3 shows a sample CEUS usefulness.
Discussion
Bosniak classification based on review of a single CT of a cyst might be insufficient to determine optimal treatment strategy. Further morphological assessment using more accurate imaging examinations appears necessary.
In this context, the present results suggested that CEUS provides higher diagnostic accuracy than MRI or CT. Standard US has a low contrast resolution combined with high acoustic disturbance, and Doppler is too limited for the detection of microvessels. This explains the need to use CT and MRI to assess or characterize the nature of cysts. 13, 14 However, these two examinations might not be completely helpful, because the phenomenon of partial volume is high, and the contrast resolutions of CT and the spatial resolutions of MRI are poor. Indeed, they are too limited for assessment of small renal lesions, whereas the spatial resolution of US is optimal for this category of lesion. [15] [16] [17] Using contrast during US enables enhancement of this examination. This method requires intravenous injections of microbubbles, allowing exclusive intravascular marking when detecting microbubbles in cyst walls or septa. There is neither enhancement of the urinary route nor accumulation in the renal parenchyma, which eases exploration. 15 CEUS is a valuable tool to identify contrast enhancement in the cysts septa or wall, or septal or mural nodules. This is due to the high sensitivity of the contrast-specific mode to the harmonic signals produced by microbubbles, which probably makes CEUS even more effective than contrast material-enhanced CT and MR in the detection of contrast enhancement in cystic renal tumors. However, some limitations inherent to the technique have to be considered: back shadowing from calcification, bowel gas interposition and US beam attenuation in cases of deep lesion location can obscure contrast enhancement after microbubble injection. Although we enrolled several obese patients, they were too rare to assess the impact of a high body mass index on the results of CEUS in the present study. CEUS might be too sensitive, as it can detect only a few microbubbles traveling in thin septa with a superior time and spatial resolution compared with any other imaging modalities, leading to overclassifying certain cases of benign cysts.
The findings in the present study were close to those already reported in the literature, showing the high diagnostic performance of CEUS. Indeed, we found a sensitivity and specificity of 100% and 97%, respectively. These findings are close to those reported by Bertolotto et al. in a study also including 47 patients, and in which they used the same definition for the final diagnosis. Their two radiologists found a sensitivity of 96.7% and 93.3%, respectively, and a specificity of 94.1%. 8 Furthermore, Chen et al. in their study on 59 patients, reported a sensitivity of 97.2% and a specificity of 71.4% using the same definition for the final diagnosis. 9 Furthermore, similar to the present findings, Chen et al. also reported a high rate of diagnostic accuracy (84.5%), a low rate of undetected cancers (2.8%) and a high kappa coefficient (0.7). 9 The values we found were greater than those already reported in the literature. These differences might be explained by the operator-dependent variation of US even though Bertolotto et al. reported a good match between the results of their two operators (j = 0.7). Also, in the present study, surgical treatment was guided mainly by MRI and US examination, which could lead to a potential selection bias among tumors with histological analysis. 8 Finally, Barr et al., in a large retrospective study of 721 patients with indeterminate renal mass on CT, found similar results to ours on CEUS with 100% sensitivity, 95% specificity, 94.7% positive predictive value and a 100% negative predictive value. 16 That study did not include only cystic tumors; however, Aoki et al. reported similar results for both solid and cystic tumors on CEUS. 16, 18 Recently, Graumann et al. reported different results in a prospective study including 46 patients. Indeed they found that CEUS and MRI results were both in agreement with CT diagnosis with a high kappa score (0.86 and 0.91, respectively), and they concluded that enhanced CT should remain the gold standard for the Bosniak classification. 19 However, these discrepancies with the present results could be explained by different methods. First, in their study, they included a majority of Bosniak 2 (n = 27), which are less problematic for CT diagnosis than Bosniak 2F or 3 cysts, representing just 19 cases, whereas we included only such cysts. Furthermore, they chose the CT diagnosis as the standard for the CEUS and MRI accuracy assessment, and histological data were available for just six patients. In the present study, we used the final diagnosis as previously described using histological data, when available, or follow-up data. This method provided an accuracy assessment independently from the CT results, that could be more relevant. MRI has already been reported to be more accurate than CT for the evaluation of renal cysts. 3 Indeed, applied to MRI, the Bosniak classification leads to an increase in the number of lesion categories detecting more septa, by thoroughly analyzing the thickness of the septa or walls and their enhancement. 3 The present study has also suggested the superior diagnostic performance of MRI compared with CT. Furthermore, the diagnostic performance of MRI we found was close to that reported by Chen et al.: sensitivity of 80.6%, a specificity of 77.1%, a PPV of 78.4%, a NVP of 79.4% and a kappa coefficient of 0.58. 9 Thus, MRI is a more accurate examination compared with CT, but nevertheless potentially inferior to CEUS. 3, 16, 20 Cystic tumors represent up to 10% of renal cell cancers. 2 As far as a CT diagnosis is concerned, Bosniak category 2F cysts are associated with malignant tumors in 5-20% of cases, and with a high disparity between the series. 6 For Bosniak category 3, from 20% to more than 50% of malignancies have been reported. 4, 6 In the present series, 26% of Bosniak category 2F cysts and 39% of Bosniak category 3 cysts according to initial CT corresponded to malignant tumors. These findings were close to those expected, even though the rate of malignant tumors for category 2F lesions was superior to that reported in the literature.
One of the main limitations of the present study was the low number of patients included. However, the population samples found in the literature for prospective studies on this topic were also low. Despite exclusion of low-quality CT, included examinations had heterogeneous slice thickness, up to 2.5 mm, that could have affected the CT results. Furthermore, CEUS is operator dependent. In the present study, as in other series, only an expert radiologist carried out these examinations. The present findings are also representative of the value of CEUS in expert hands, but not necessarily relevant in daily practice. However, this point underlines the need to refer such types of lesions to tertiary care referral centers, which are used to carrying out these examinations. This is indeed recommended in some guidelines. 21 Finally, our primary end-point, for 28 patients, was based on lesion progression during imaging follow up, and in the absence of histological evidence. This was less reliable than histology diagnosis, and might also be limited because of the relatively short follow up, which was less than the 5-year observation period recommended for Bosniak 2F cysts. 6, 22 In conclusion, the present results suggested the diagnostic performance of CEUS in improving the characterization of complex renal cysts, which can be limited in some cases if using only CT scan or MRI. CEUS appeared to be a relevant examination to achieve accurate diagnosis and to optimize treatment strategy of complex renal cysts. 
